Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-24 @ 6:33 PM
NCT ID:
NCT00614757
Eligibility Criteria:
Inclusion Criteria:
* Ability to give written consent
* HCV RNA PCR positive for 6 months
* Normal Hgb, WBC,Neutrophils
* Platelets of \>/= 65,000
* Direct Bili, within 20% ULN
* Albumin \>3
* Serum Creatinine \<20% ULN
* TSH WNL
* AFP \</= 100
Exclusion Criteria:
* Women who are pregnant or breast-feeding
* No Thiazolidinedione, Metformin,unless required for the treatment of type II DM
* Hepatitis C of non-genotype 1,2,3
* Any other cause for liver disease other than chronic hepatitis C
* Hemoglobinopathies
* Evidence of advanced liver disease
* Previous organ transplant
* Severe psychiatric disorder
* Significant cardiovascular dysfunction within the past 12 months
* Poorly controlled diabetes mellitus
* Immunologically mediated disease
* Any medical condition requiring chronic systemic administration of steroids
* Evidence of an active or suspected cancer
* Substance abuse at the time of the study
* Known HIV
* Irritability or unwillingness to provide informed consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00614757
Study Brief:
Protocol Section:
NCT00614757